Lower oxygen levels may improve IVF embryo development

A new study in mice suggests that culturing IVF embryos at lower oxygen levels could lead to better fetal and placental development. Researchers found that 2 per cent oxygen more closely matched natural conception than the current 5 per cent standard. The findings were published on bioRxiv.

Marisa Bartolomei at the University of Pennsylvania and her team cultured mouse embryos at either 2 per cent or 5 per cent oxygen before transferring them to recipient mice. They tracked the offspring for 12 weeks after birth.

Embryos grown at 2 per cent oxygen showed epigenetic patterns closer to those of naturally conceived embryos. In contrast, those at 5 per cent had more trophectoderm cells, which may contribute to thicker placentas and lower birth weights observed in IVF pregnancies.

Amy Sparks at the University of Iowa called the work a “landmark paper that we will cite for decades to come”. Bartolomei noted that while changing incubators would add some cost, it remains modest compared with overall IVF expenses.

Further safety and efficacy tests in larger animals and humans are still needed before any clinical changes.

Related Articles

Researchers have achieved the first live births in a large animal using an experimental IVF method that matures highly immature eggs in the lab. The breakthrough in sheep could eventually help boost human fertility treatment options, particularly for those affected by cancer therapies.

Reported by AI

A single mRNA injection can halve the rate of chromosome errors in human eggs from older women, according to new research presented at a London conference. The treatment targets a protein deficiency that contributes to aneuploidy, a common cause of IVF failure and miscarriage. Researchers say the approach shows promise for improving fertility outcomes.

A study in mice has found that transplanting gut microbes from young animals into older ones can restore youthful levels of brain plasticity. The research points to potential new ways of treating conditions that are normally only reversible in childhood.

Reported by AI

Researchers at Johns Hopkins Medicine created lab-grown brain organoids from cells of people with Alzheimer’s disease to study how they respond to the antidepressant escitalopram oxalate.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline